ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02268851
Brief Title: A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL or MCL

First Submitted : October 16, 2014
First Submitted that Met QC Criteria : October 16, 2014
First Posted : October 20, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : February 6, 2019
Last Update Posted : February 8, 2019